Neuronox

DRUG3 trials

Sponsors

Medy-Tox

Conditions

Essential BlepharospasmGlabellar LinesOveractive Bladder

Phase 3

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

CompletedNCT03216408

Medy-ToxGlabellar Lines

Start: 2016-03-30End: 2017-03-07Updated: 2017-07-13

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

CompletedNCT03216473

Medy-ToxEssential Blepharospasm

Start: 2016-05-25End: 2017-07-04Updated: 2017-07-13

Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

Medy-ToxOveractive Bladder

Start: 2019-08-23End: 2021-08-31Updated: 2020-07-28